Gaviscon and Conjunctivitis exacerbated - a phase IV clinical study of FDA data

Summary:

Conjunctivitis exacerbated is reported as a side effect among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate), especially for people who are female, 40-49 old, also take Acetaminophen, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Conjunctivitis exacerbated when taking Gaviscon. It is created by eHealthMe based on reports of 11,990 people who have side effects when taking Gaviscon from the FDA, and is updated regularly.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

What is Conjunctivitis exacerbated?

Conjunctivitis exacerbated (bad situation of conjunctivitis) is found to be associated with 1,067 drugs and 426 conditions by eHealthMe. Check the latest studies of Conjunctivitis exacerbated.

On Jul, 13, 2026

11,990 people reported to have side effects when taking Gaviscon.
Among them, 13 people (0.11%) have Conjunctivitis exacerbated.

Could Gaviscon cause Conjunctivitis exacerbated?

Among these 13 people:

What is the gender of people who have Conjunctivitis exacerbated when taking Gaviscon? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Conjunctivitis exacerbated when taking Gaviscon? *

What are other drugs people take besides Gaviscon? *

Famotidine: 7 people, 53.85%
Olopatadine Hydrochloride: 7 people, 53.85%
Epinephrine: 7 people, 53.85%
Montelukast Sodium: 7 people, 53.85%
Flonase: 7 people, 53.85%
Acetaminophen: 7 people, 53.85%
Prilosec: 6 people, 46.15%
Colace: 5 people, 38.46%
Gabapentin: 5 people, 38.46%
Augmentin: 5 people, 38.46%

What are other side effects people have besides Conjunctivitis exacerbated? *

Headache (pain in head): 10 people, 76.92%
Nausea (feeling of having an urge to vomit): 9 people, 69.23%
Fatigue (feeling of tiredness): 9 people, 69.23%
Urinary Tract Infection: 8 people, 61.54%
Viral Infection: 7 people, 53.85%
Infusion Site Pain: 7 people, 53.85%
Chills (felling of cold): 7 people, 53.85%
Infusion Site Erythema (reddening of the skin at infusion site): 7 people, 53.85%
Rashes (redness): 7 people, 53.85%
Weight Decreased: 6 people, 46.15%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 7 people, 53.85%
Primary Immunodeficiency Syndrome: 3 people, 23.08%
Pulmonary Congestion (congestion in the lungs): 1 person, 7.69%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.69%
Oesophageal Candidiasis (fungal infection of oesophagus): 1 person, 7.69%
Nausea (feeling of having an urge to vomit): 1 person, 7.69%
Mixed Connective Tissue Disease (an autoimmune disease, in which the body's defence system attacks itself): 1 person, 7.69%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 7.69%
Impaired Gastric Emptying: 1 person, 7.69%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Gaviscon and have Conjunctivitis exacerbated?

- Check whether Conjunctivitis exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gaviscon:

Gaviscon (12,355 reports)

Conjunctivitis exacerbated treatments and more:

Conjunctivitis exacerbated (5 reports)

How severe was Conjunctivitis exacerbated and when was it recovered:

Conjunctivitis exacerbated in Gaviscon

Expand to all the drugs that have ingredients of aluminum hydroxide; magnesium trisilicate:

Conjunctivitis exacerbated and drugs with ingredients of aluminum hydroxide; magnesium trisilicate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (1,067 drugs)

Browse all the conditions that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (426 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aluminum hydroxide; magnesium trisilicate (the active ingredients of Gaviscon) and Gaviscon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.